Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Hypersensitivity
ADR ID BADD_A02145
ADR Hierarchy
10      Immune system disorders
10.01      Allergic conditions
10.01.03      Allergic conditions NEC
10.01.03.003      Hypersensitivity
Description Altered reactivity to an antigen, which can result in pathologic reactions upon subsequent exposure to that particular antigen. [MeSH]
MedDRA Code 10020751
MeSH ID D006967
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Acute allergic reaction | Allergic reaction | Allergic reaction NOS | Allergy | Allergy aggravated | Allergy NOS | Allergy, unspecified, not elsewhere classified | Hypersensitivity | Hypersensitivity NOS | Hypersensitivity reaction | Hypersensitivity reaction (NOS) | Hypersensitivity symptom | HYSN | Reaction allergic (NOS) | Reaction hypersensitivity (NOS) | Red neck syndrome | Allergic reaction (NOS) | Environmental allergy | Systemic allergic reaction | Hypersensitivities | Allergies | Allergic Reaction | Allergic Reactions | Reaction, Allergic | Reactions, Allergic
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02384Zileuton--
BADD_D02389Ziprasidone hydrochloride--
BADD_D02391Ziprasidone mesylate--
BADD_D02392Zoledronic acid--
BADD_D02393Zolmitriptan--
BADD_D02394Zolpidem0.000843%
BADD_D02395Zolpidem tartrate--
BADD_D02396Zonisamide0.001326%
BADD_D02397Zopiclone--
BADD_D02398Zuclopenthixol--
BADD_D02404Latanoprostene bunod0.000913%
BADD_D02411Voxelotor-
BADD_D02412Octreotide0.000652%
BADD_D02415Ziprasidone0.001591%
BADD_D02428Loperamide--
BADD_D02432Glycopyrronium--
BADD_D02445Solifenacin0.001320%
BADD_D02449Milnacipran0.008466%
BADD_D02450Crisaborole0.013832%
BADD_D02452Icatibant-
BADD_D02456Vilazodone0.004121%
BADD_D02457Dexmethylphenidate0.001159%
BADD_D02465Aclidinium0.001302%
BADD_D02466Levomilnacipran0.000212%
BADD_D02471Oxygen--
BADD_D02473Sodium chloride0.002462%
BADD_D02491Valbenazine0.028156%
BADD_D02492Deflazacort0.000717%
BADD_D02496Elagolix0.001453%
BADD_D02500Alpelisib0.002921%
The 45th Page    First    Pre   45 46    Next   Last    Total 46 Pages
ADReCS-Target
ADR Term Drug Name Target